Skip to main content
. 2022 Sep 8;11(3):58. doi: 10.3390/antib11030058

Table 5.

HLA-Ia Ab profiles in the sera of normal non-alloimmunized male volunteers after purification of IgG using Protein-G affinity purification columns, elaborate the profile of the naturally occurring anti-HLA-I antibodies, suggesting that under natural conditions these antibodies may be masked by other factors, such as anti-idiotypic antibodies and immune complexes.

Mr Ho Rn Th Sk Vd Me Cr Ad
NC (Albumin) 862 2101 940 1652 5052 1451 874 2752 1326
Anti-HLA-A IgG profile after affinity purification A*0101 631 1697 747 1255 1352 505 646 1895 804
A*0201 661 1563 797 1209 1668 648 2172 878
A*0203 712 1641 756 1155 1727 604 2064 886
A*0206 789 1804 911 1324 2127 518 730 2650 965
A*0301 833 2197 911 1587 1898 555 733 2408 1018
A*1101 970 2645 1066 1639 2053 730 808 2892 1132
A*1102 741 1684 1056 1277 1662 579 637 2044 949
A*2301 897 2980 1133 1857 2007 688 1074 2841 1193
A*2402 1196 2967 1299 2284 2576 776 1175 3558 1437
A*2403 1016 2446 1108 1931 2261 687 894 2519 1238
A*2501 702 1847 804 1207 1576 505 693 2322 942
A*2601 1104 3401 1136 1976 2125 797 988 2721 1272
A*2901 902 2911 1013 1720 1640 778 892 2870 1090
A*2902 927 4136 1044 1781 2150 784 869 2832 1145
A*3001 1063 2421 1080 1751 3524 702 891 2540 1227
A*3002 686 1780 797 1286 1631 519 636 2077 896
A*3101 656 2074 741 1164 1746 615 2351 801
A*3201 779 3294 866 1523 1533 660 772 2249 966
A*3301 994 2807 958 1761 2475 669 835 2668 1111
A*3303 752 2229 806 1357 1804 646 2177 891
A*3401 1141 3851 1162 2004 2741 858 1121 2746 1272
A*3402 688 1675 778 1258 1546 513 663 2195 861
A*3601 881 1977 924 1510 1848 652 750 2257 1010
A*4301 1114 3782 1180 2081 2452 709 963 2308 1342
A*6601 924 3247 935 1575 2620 615 785 2061 1066
A*6602 983 3189 972 1759 3099 643 826 2226 1069
A*6801 651 1427 705 1236 1587 673 1914 775
A*6802 932 2216 1065 1555 2094 989 750 3338 983
A*6901 1262 2777 1314 2237 2614 835 1138 2835 1521
A*7401 875 2719 897 1519 1734 602 755 1802 1025
A*8001 931 2885 1033 1676 2282 730 876 2141 1127
Anti-HLA-B IgG profile after affinity purification B*0702 699 1549 825 1193 1792 657 2036 839
B*0801 796 2020 890 1447 1650 556 703 2576 975
B*1301 1331 3178 1356 2231 2725 817 1088 3103 1461
B*1302 967 2500 1096 1639 2385 660 837 2697 1126
B*1401 1198 2702 1231 2022 2203 950 1162 2876 1368
B*1402 977 2439 1093 1797 2176 748 919 2324 1093
B*1501 747 1602 860 1329 2026 718 2134 945
B*1502 942 2610 1070 1764 2453 637 928 2745 1233
B*1503 986 2277 1039 1724 2208 595 739 2588 1130
B*1510 965 2934 1047 1714 2138 742 887 2357 1175
B*1511 1443 3526 1473 2466 2989 1010 1169 3462 1567
B*1512 751 2163 829 1496 2721 2523 3030 1147
B*1513 1232 2917 1321 2105 2597 839 1097 2868 1455
B*1516 1205 4241 1389 2398 2725 1360 1199 3158 1503
B*1801 752 2024 853 1400 1641 565 658 2196 912
B*2705 595 1378 681 1084 2021 589 1990 764
B*2708 551 1514 651 932 1669 520 2107 711
B*3501 940 2199 1003 1667 2216 608 864 3054 1195
B*3701 1518 4054 1967 2613 2897 949 1259 3369 1540
B*3801 1191 2110 1095 1706 2060 621 853 2778 1160
B*3901 575 1291 657 1051 1446 520 1800 757
B*4001 781 1980 910 1448 1761 520 698 3228 980
B*4002 624 1669 713 1124 1313 575 2044 783
B*4006 1354 3682 1403 2280 2773 1006 1109 3287 1511
B*4101 760 1823 848 1413 1659 528 688 2299 940
B*4201 694 1603 765 1160 2014 632 2121 857
B*4402 1121 2455 1196 1885 2067 710 2587 2575 1230
B*4403 811 2028 1044 1382 1972 515 2353 2474 932
B*4501 756 1814 786 1325 1780 500 2709 2221 918
B*4601 1090 2941 1466 2220 2396 898 1163 3297 1470
B*4701 879 2687 994 1729 1867 670 823 2567 1064
B*4801 1015 2291 1088 1769 1908 770 858 3066 1173
B*4901 929 2200 978 1725 2046 580 820 2569 1168
B*5001 675 1898 784 1207 1563 500 607 2152 880
B*5101 1118 2580 1214 2079 2259 724 973 2494 1355
B*5102 1116 2754 1140 1997 2271 842 976 2609 1341
B*5201 1050 3355 1227 1934 2261 744 982 2391 1299
B*5301 1251 3024 1359 2264 2474 845 1100 2725 1469
B*5401 1011 2528 1101 1737 2264 748 859 2661 1192
B*5501 955 2327 1020 1629 2089 599 806 2427 1111
B*5601 907 2698 1025 1594 2244 553 843 2667 1186
B*5701 762 2155 937 1512 2081 538 723 2144 990
B*5703 995 2740 1171 1864 2345 746 953 2789 1218
B*5801 1338 3218 1424 2331 3213 924 1185 2930 1523
B*5901 1155 2730 1207 1960 2502 766 1002 2600 1377
B*6701 661 1601 827 1180 1895 709 700 2412 841
B*7301 842 2326 960 1590 2458 555 932 2132 1085
B*7801 1150 2527 1186 1964 2544 743 948 2538 1346
B*8101 910 2241 1117 1658 2130 649 790 3022 1100
B*8201 2293 2886 1288 2311 2168 864 1006 2819 1445
Anti-HLA-C IgG profile after affinity purification C*0102 1740 4894 1735 2972 2873 1221 1397 3892 1684
C*0202 1941 4568 1894 3222 3936 1410 1504 3505 2011
C*0302 1830 4391 1829 3077 3369 1169 1512 3621 1967
C*0303 1663 3828 1602 2839 2851 1182 1409 3076 1849
C*0304 1900 4334 1801 2974 3272 1234 1538 3437 1977
C*0401 2166 6468 2126 3870 3863 1587 1897 3951 2305
C*0501 1967 3806 1726 3015 3404 1216 1912 3560 1886
C*0602 2165 4446 2175 3835 3672 1627 1732 4236 2108
C*0702 2551 5861 2388 4231 4327 1721 2066 4513 2605
C*0801 1510 3273 1467 2541 2896 1004 1218 3105 1555
C*1203 1588 3638 1551 2763 3129 1279 1382 3905 1674
C*1402 2077 5509 2009 3508 3440 1425 1640 3862 2073
C*1502 1408 3095 1375 2598 2614 1086 1183 3487 1481
C*1601 1724 4233 1739 3118 3473 1363 1526 3727 1967
C*1701 1857 4062 2103 3552 3823 1368 1625 3703 1991
C*1802 2275 4848 2292 3959 3990 1632 2054 4296 2353

The change in the number and strength of sera IgG antibodies against albumin, HLA-A, HLA-B and HLA-C, after affinity purification. Compare with Table 4 which shows the number and strength of these antibodies in raw sera. * Suggesting that the individuals may possibly carry naturally occurring antibodies formed against most commonly shared epitopes.